Login / Register for free to get access to My MedWorm

PharmaceuticalsPharmaceuticals RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. subscribe with MyMedWormSubscribe to this data using MyMedWorm.subscribe with GoogleReaderSubscribe to this data using GoogleReader.subscribe with BloglinesSubscribe to this data using Bloglines.subscribe with MyYahooSubscribe to this data using MyYahoo.

This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 14.

Bristol in Deal for Arthritis Drugemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Bristol-Myers Squibb reached an agreement that could result in the company paying more than $1 billion for exclusive rights to develop a rheumatoid arthritis treatment by privately held Alder.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news

ImmunoGen, Inc. Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeuticsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 10, 2009 - ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that several ImmunoGen poster presentations will be made at...
Source: Drugs.com - Clinical Trials - November 10, 2009 Category: Pharmaceuticals Source Type: clinical trials

Bristol in Deal for Alder's Arthritis Drugemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Bristol-Myers Squibb reached an agreement that could result in the company paying more than $1 billion for exclusive rights to develop a rheumatoid arthritis treatment by privately held Alder.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news

Trading Outlook for Tenet Healthcare Corporation Issued by StockPreacher.comemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
DALLAS, Nov. 10, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Tenet Healthcare Corporation (NYSE:THC). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - November 10, 2009 Category: Pharmaceuticals Source Type: news

TRIN Pharma Starts Phase I Clinical Trial Of TRIN 2755 In Solid Tumorsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
TRIN Pharma GmbH, specializing in the development of small molecule drugs for tumor treatment, announced today that BfArM, the German regulatory authority, has approved the start of a Phase I clinical trial of TRIN 2755 in solid tumors.
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news

NexBio(R) Presents Data Showing Anti-Asthma Activity Of DAS181 (Fludase(R)) At ACAAI 2009email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
NexBio, Inc. announced the presentation of new data at the 2009 annual American College of Allergy, Asthma, and Immunology in Miami, Florida. The presentation was entitled "DAS181 (Fludase®), a Sialidase, Decreases Airway Resistance and Has Potent Anti-inflammatory Effects in Animal Models of Asthma".
Source: Pharma Industry News From Medical News Today - November 10, 2009 Category: Pharmaceuticals Tags: Respiratory / Asthma Source Type: news

1st Symposium On Scale Up Of Oral Solid Dosage Formsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
GEA Pharma Systems joined forces with Evonik Industries last month to present their first ever joint symposium on 'Scale up of Oral Solid Dosage Forms'. The event was held at the Hotel Bad Bubendorf in Switzerland and co-hosted by Dr. Harald Stahl of GEA Pharma Systems and Dr. Bridgitte Skalsky of Evonik Röhm GmbH.
Source: Pharma Industry News From Medical News Today - November 10, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news

GSK signs agreement with the WHO to donate 50 million doses of pandemic H1N1 vaccine for distribution to developing countriesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
GlaxoSmithKline (GSK) today announced that it has signed an agreement with the World Health Organization (WHO) to donate 50 million doses of its adjuvanted pandemic H1N1 influenza vaccine to WHO for distribution to developing countries most in need.
Source: GSK news - November 10, 2009 Category: Pharmaceuticals Source Type: organizations

Roche reports positive Phase II results with potential first-in-class treatment for the negative symptoms of schizophreniaemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Roche today reports results from a 320 patient phase II proof-of-concept study with it’s investigational glycine transporter-1 inhibitor RG1678. The study showed that the compound improved both the negative symptoms and the personal and social functioning of patients with schizophrenia reaching statistical significance on primary and secondary endpoints.
Source: Roche Investor Update - November 10, 2009 Category: Pharmaceuticals Source Type: organizations

Homogeneous Fluorescence-Based Assay For Detecting Intracellular Calcium Mobilisationemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Amsbio's Screen Quest Calcium Assay kit provides a homogeneous fluorescence-based assay for detecting intracellular calcium mobilisation across a broad spectrum of biological targets.
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news

Patheon, Inc. Adds Two Key Industry Leaders To Its Pharmaceutical Development Services Businessemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced recently that it has named William E. Weiser, Ph.D. as group director, Pharmaceutical Development Services (PDS), Analytical Development at the company's Kit Creek laboratory located in Research Triangle Park, N.C.
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news

Bristol-Myers Squibb And Alder Biopharmaceuticals Enter Global Agreement On Rheumatoid Arthritis Biologicemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Bristol-Myers Squibb Company and Alder Biopharmaceuticals, Inc., recently announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.
Source: Pharmaceutical Online News - November 10, 2009 Category: Pharmaceuticals Source Type: news

Obesity Fight May Take a Villageemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Officials in a number of countries are pursuing a new anti-obesity strategy: enlisting communities to insulate people from the temptations of modern life and make healthier choices easier.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

A New Front in Heart Disease Battleemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Two major cardiology organizations are targeting a new front in the battle to improve the quality and efficiency of heart care: the physician's office.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Abortion Foes Take Aim at Health Billemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The abortion issue could impede a Senate health bill. Sen. Ben Nelson, a swing vote, is "highly unlikely" to back a bill that lacks tough antiabortion curbs similar to those in the House version.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Aid for Elderly May Raise Costs for Youngemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
A provision in the House health-care bill sets up a stark choice for Democrats between the interests of younger voters and older ones.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Catholic Church Sways Health Fightemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The Roman Catholic Church in America has emerged as a major political force with the potential to upend Obama's health-care agenda.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Aid for Elderly May Raise Costs for Youngemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
A provision in the House health-care bill sets up a stark choice for Democrats between the interests of younger voters and older ones.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Catholic Church Sways Health Fightemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The Roman Catholic Church in America has emerged as a major political force with the potential to upend Obama's health-care agenda.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Doctors Fight Heart Disease in the Officeemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Two major cardiology organizations are targeting a new front in the battle to improve the quality and efficiency of heart care: the physician's office.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Abortion Foes Take Aim at Health Billemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The abortion issue could impede a Senate health bill. Sen. Ben Nelson, a swing vote, is "highly unlikely" to back a bill that lacks tough antiabortion curbs similar to those in the House version.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

A Scent to De-Stress Petsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
If Fido is stressed out, maybe he just needs a whiff of pheromones. Aches & Claims looks at the scientific evidence behind a growing array of animal pheromone products.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Doctors Battle Heart Disease in the Officeemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Two major cardiology organizations are targeting a new front in the battle to improve the quality and efficiency of heart care: the physician's office.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Pfizer to Close 6 Research Sitesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Pfizer, digesting its $68 billion takeover of rival Wyeth, will close six of its 20 research sites in the latest round of cost cutting by drug makers.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news

New Swine Flu Victim: Blood Supplyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The swine-flu pandemic is creating unexpected problems for the nation's blood supply—keeping some donors away and raising questions whether the flu can be spread through a blood transfusion.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Aiding Elderly May Raise Costs for Youngemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
A provision in the House health-care bill sets up a stark choice for Democrats between the interests of younger voters and older ones.
Source: WSJ.com: Health - November 10, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

International Diabetes Federation drives global action ahead of World Diabetes Dayemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
In many countries, November is diabetes awareness month, with November 14 - World Diabetes Day - the most significant date on the diabetes calendar. The need to increase diabetes awareness grows ever year with the increasing impact of the disease worldwide.
Source: World Pharma News - November 10, 2009 Category: Pharmaceuticals Source Type: news

New Swine Flu Victim: Blood Supplyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The swine-flu pandemic is creating unexpected problems for the nation's blood supply—keeping some donors away and raising questions whether the flu can be spread through a blood transfusion.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

When Hoarding Hurts Othersemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Compulsive hoarding is coming out of the closet these days, thanks to books, movies and TV shows. But many family members say the pain that hoarding inflicts on them is still largely unacknowledged.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Fighting Obesity May Take a Villageemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Officials in a number of countries are pursuing a new anti-obesity strategy: enlisting communities to insulate people from the temptations of modern life and make healthier choices easier.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Abortion Fight Turns to the Senateemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abortion-rights supporters and opponents turned their attention to the Senate on Monday after the House voted over the weekend to restrict abortion coverage under its health-overhaul bill.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Indian generic firms to gain from Obama’s healthcare billemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The Indian generic companies expect to gain from the Obama government’s new healthcare bill which could lead to increased consumption of generic drugs.
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Fighting Obesity May Take a Villageemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Government officials in a number of countries are pursing an aggressive new anti-obesity strategy: enlisting entire communities to insulate people from the temptations of modern life and make healthier choices easier.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Govt plans new norms for ads on emergency contraceptive pillsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
The government has decided to frame guidelines on advertisements of emergency contraceptive pills (ECP) to ensure consumers be aware of the side-effects of the product.
Source: The Economic Times Healthcare and Biotech News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Buy-out groups see off Apoteket's peersemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Private equity groups triumphed over several industrial groups – including Alliance Boots – in the $858m auction of Sweden's state-owned pharmacy chain
Source: FT.com - Drugs and Healthcare - November 9, 2009 Category: Pharmaceuticals Source Type: news

Abortion Fight Turns to the Senateemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Abortion-rights supporters and opponents turned their attention to the Senate on Monday after the House voted over the weekend to restrict abortion coverage under its health-overhaul bill.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news

Cerner Announces Variable Prepaid Forward Contract on Cerner Stock by Chairman Neal Patterson and Vice Chairman Clifford Illigemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
KANSAS CITY, Mo., Nov. 9, 2009 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq:CERN) today announced that Chairman Neal Patterson and Vice Chairman Clifford Illig have each entered into a variable prepaid forward contract covering 500,000 shares of Cerner common stock.
Source: Medical News (via PRIMEZONE) - November 9, 2009 Category: Pharmaceuticals Source Type: news

QIAGEN Reports Strong Third Quarter 2009 Resultsemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
VENLO, The Netherlands, Nov. 9, 2009 (GLOBE NEWSWIRE) -- QIAGEN N.V. (Nasdaq:QGEN) (Frankfurt:QIA) today announced the results of operations for the third quarter and the nine-month period ended September 30, 2009.
Source: Medical News (via PRIMEZONE) - November 9, 2009 Category: Pharmaceuticals Source Type: news

SuperGen Presentations at AACR-NCI-EORTCemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
DUBLIN, Calif.--(BUSINESS WIRE)--Nov 9, 2009 - SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced the acceptance of seven abstracts for poster presentations on...
Source: Drugs.com - Clinical Trials - November 9, 2009 Category: Pharmaceuticals Source Type: clinical trials

NexBio Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009email this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
    SAN DIEGO, November 09, 2009 /PRNewswire/ -- NexBio, Inc. announced the presentation of new data at the 2009 annual American College of Allergy, Asthma, and Immunology in Miami, Florida. The presentation was entitled "DAS181...
Source: Drugs.com - Clinical Trials - November 9, 2009 Category: Pharmaceuticals Source Type: clinical trials

OssulinTM, a Novel Oral Insulin Product, Shows Promising Bioavailability for Advancing Diabetes Therapyemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Data Presented at San Francisco Diabetes Conference LONDON--(BUSINESS WIRE)--Nov 9, 2009 - New data from Puredel Limited, presented at the 9th Annual Diabetes Technology Meeting in San Francisco, CA, suggests that higher blood levels of insulin were...
Source: Drugs.com - Clinical Trials - November 9, 2009 Category: Pharmaceuticals Source Type: clinical trials

CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Responseemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
STUDIES SUPPORTIVE OF ROLE THAT TECHNOLOGY CAN PLAY IN TREATMENT OF H1N1 HOSPITALIZED PATIENTS VIENNA, Va., Nov. 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that Dr. Kenneth S. Rosenthal, Professor of Immunology...
Source: Drugs.com - Clinical Trials - November 9, 2009 Category: Pharmaceuticals Source Type: clinical trials

Monsanto to Purchase Chesterfield Village Research Center From Pfizeremail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
ST. LOUIS, Nov. 9, 2009 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) and Pfizer Inc (NYSE:PFE) today announced that they have entered into an agreement for Monsanto to acquire Pfizer's Chesterfield Village Research Center located in...
Source: Drugs.com - Pharma News - November 9, 2009 Category: Pharmaceuticals Source Type: news

Pfizer to Close 6 Research Sitesemail this articleEmail this article to a colleague. save this article to My ClippingsSave this article to My Clippings. discuss this articleDiscuss or comment on this article.
Pfizer, digesting its $68 billion takeover of rival Wyeth, will close six of its 20 research sites in the latest round of cost cutting by drug makers.
Source: WSJ.com: Health - November 9, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news